Cargando…
Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study
Docetaxel has been reported to show promising anti-tumour activity in pancreatic ductal cancer (PC). This study was conducted to evaluate the activity and toxicity of moderate-dose (60 mg m(−2)) docetaxel in Japanese chemo-naive patients with measurable metastatic PC. The patients had a performance...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1999
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362341/ https://www.ncbi.nlm.nih.gov/pubmed/10408850 http://dx.doi.org/10.1038/sj.bjc.6690375 |